<b>Conclusions:</b> CL activates the NLRP3 inflammasome pathway in TIL from patients with GI cancer and increases CXCL9/CXCL10 expression in TIL, resulting in enhanced recognition of mutant cancer-associated target epitopes, including a mitochondrial protein. Here, NLRP3 is linked to cancer.